You are here

Biodefense

ST Support to the COVID-19 Response

The Science and Technology Directorate (S&T) is harnessing the knowledge of its experts to help in response to COVID-19. It has focused its efforts on laboratory research and providing valuable resources to inform the broader response community and help keep front line responders safe.

The President's Biodefense Strategy

The President's Biodefense Strategy

As the president’s September 2018 National Biodefense Strategy states, “Health security means taking care of the American people in the face of biological threats to our homeland and to our interests abroad.”

S&T DHS Biosafety Directive

This Directive and the accompanying Instruction establish the authorities,responsibilities, requirements, and procedures for Biosafety in all activities conducted or sponsored by the Department of Homeland Security (OHS). This Directive adopts the principles of the current edition of the U.S. Health and Human Services Centers for Disease Control and Prevention and National Institutes of Health Biosafety in Microbiological and Biomedical Laboratories and its recommendations for standards, practices, equipment, and facilities for biological laboratory activities, as well as the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guidelines) and other related guidance listed in Part Ill.

Snapshot: S&T develops five new powerful tools to combat FAD

DHS S&T recently filed five patent applications with the U.S. Patent and Trademark Office and provided the funding for research performed by collaborating federal scientists to file five additional patent applications to provide powerful new tools to combat Foreign Animal Diseases (FADs), specifically Foot-and-Mouth Disease (FMD) and African Swine Fever.

Pages

Subscribe to Biodefense
Back to Top